Best Hcv Podcasts (2026)

1
Carrying the Story Forward with Raymond Velazquez-Turner 1:05:54

Play Pause

14d ago1:05:54

1:05:54

Episode 4 of the four part series funded by the Counter Narrative Project. Carrying the story forward; lived experience, leadership, and harm reduction. Come along as we discuss idenity, substance use, HIV, sex work, housing, and fighting healthcare stigma. Raymond Velazquez-Turner is a public health leader and harm reduction advocate working with …

1
Episode 20: Understanding broadly protective immune responses to develop pandemic virus vaccines 23:37

6d ago23:37

23:37

We talk with Dr. Anass Abbad, a postdoctoral fellow in the Department of Microbiology at the Icahn School of Medicine Mount Sinai, NY who studies humoral immune responses and virus-host receptor interactions to design next generation pandemic virus vaccines.By CVIMP

1
Decera Clinical Education Independent Conference Coverage of IDWeek and EACS 2025: HIV Update Podcast 36:47

18d ago36:47

36:47

Tune into this podcast to revisit discussions led by global experts, Karine Lacombe, MD, PhD, and Chloe Orkin, MBChB, FRCP, MD, featuring the latest updates on HIV treatment and prevention from the 2025 IDWeek and EACS conferences. Topics covered include: Real-world safety and efficacy of long-acting ART ART switch: preferences, treatment satisfact…

1
RSV Revealed Podcast: The Role of Diagnostic Testing in Advancing Clinical Care 1:05:21

21d ago1:05:21

1:05:21

In this podcast, featuring audio from an expert roundtable video module, listen as 3 multidisciplinary faculty, Tracey Q. Davidoff, MD, FCUCM; Carina Marquez, MD, MPH; and Jeffrey D. Whitman, MD, MS, discuss the benefits of diagnosing respiratory syncytial virus (RSV) and optimal testing strategies. Topics covered include: The annual burden of RSV …

1
Rebuilding Confidence in Vaccines: Countering Misinformation During Pharmacy Visits 8:05

24d ago8:05

8:05

Every day, I hear patients share worries shaped by the growing wave of vaccine misinformation—questions that reveal just how overwhelming today’s “infodemic” has become. In this podcast, I explore what vaccine hesitancy really looks like and how pharmacists can use empathy, strong recommendations, and meaningful dialogue to help rebuild confidence …

1
Elevating the Voices of Transgender People Living With HIV 34:22

1M ago34:22

34:22

This episode focuses on hearing the voices of transgender people living with HIV and their advocates as they share what matters most to them when it comes to healthcare services and where HIV fits among those priorities. We also consider how these insights can assist healthcare professionals in configuring HIV care to better meet the needs of this …

1
Closing Gaps in STI Care Through Molecular Point-of-Care Testing 10:47

1M ago10:47

10:47

Molecular point-of-care testing has the potential to substantially mitigate the impact of sexually transmitted infections (STIs) on personal and public health. Listen in to learn how it may even limit the development of antimicrobial resistance. Topics covered include: CDC and US Preventive Services Task Force STI screening recommendations Whether …

1
Testing Is Treatment: The Power of Routine HIV Screening 16:34

1M ago16:34

16:34

The crux of HIV care and prevention is quick and accurate diagnosis. Listen in to learn from Aniruddha (Anu) Hazra, MD, and Dr. Nancy S. Miller about the advantages and potential pitfalls of different HIV testing algorithms to find out which one is best suited for your practice. Presenters: Aniruddha (Anu) Hazra, MD Associate Professor, Section of …

1
More Than a Moment: Queer Journeys Through Harm and Healing with Nathaniel Bush 47:46

1M ago47:46

47:46

The Needle and the Narrative, episode 3 of the new series with support from the Counter Narrative Project. We'll be digging into how substance use, HIV risk, and LGBTQ+ identity intersect, along with the barriers folks face in accessing affirming care and harm reduction services. Nathaniel Bush is the author of two books; one of original poetry tha…

1
Optimizing Antibiotics in Acute Bacterial Skin and Skin Structure Infections for Today 45:41

1M ago45:41

45:41

Listen in as experts Thomas P. Lodise, PharmD, PhD, and George Sakoulas, MD, FIDSA, explore tailored antibiotic strategies for diverse patients with acute bacterial skin and skin structure infections (ABSSSIs). Their insightful discussion focuses on antibiotic developments that followed publication of the IDSA practice guidelines in 2014 and the ch…

1
Overcoming Misconceptions About Candidacy for Switch: Barriers to Optimizing ART in People Living With HIV and Viral Suppression 31:31

1M ago31:31

31:31

Look beyond viral suppression to learn how people living with virologically suppressed HIV may still be candidates for antiretroviral therapy (ART) switch to improve treatment satisfaction and quality of life. Topics covered include: Reasons to consider regimen optimization in setting of viral suppression Available switch regimens, including 2-drug…

1
Modern S. maltophilia Management: Current Concepts for Best Outcomes 9:20

1M ago9:20

9:20

Join Ryan K. Shields, PharmD, MS, in the third of 3 podcasts from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. Topic…

1
Carbapenem Resistance Revisited: Reassessing Our Antibiotics of Choice 14:49

1M ago14:49

14:49

Join Marin H. Kollef, MD in the first of 3 podcasts from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. Topics covered…

1
DTR-P. aeruginosa: Pathways to Overcoming Diverse Resistance Profiles 19:14

1M ago19:14

19:14

Join Ryan K. Shields, PharmD, MS, in the second of three recap podcasts taken from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients.” Learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant …

1
Episode 19: Using structural immunology to understand protective or pathogenic antibodies 21:14

1M ago21:14

21:14

We talk with Dr. Sandhya Bangaru, a staff scientist in the Department of Integrative Structural and Computational Biology at The Scripps Research Institute, CA who uses advances in cryo-EM to understand antibody epitopes important for their antiviral protective activity and their pathogenic activity in allergic diseases.…

1
Overcoming Fear of Virologic Failure: Barriers to Optimizing ART in People Living With HIV and Viral Suppression 18:47

1M ago18:47

18:47

Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal antiretroviral therapy (ART) regimen for them. Stream this Medical Minute to learn more about key guideline recommendations regarding ART switch and reassuring clinical data regarding efficacy, tolerability, and qua…

1
Adjusting your T & I 16:32

1M ago16:32

16:32

Dispute your tax bill and search for cheaper premiums and deductibles for rental insurance

1
Integration of Genotypic RDT With Rapid Phenotypic AST for Bloodstream Infections 17:55

2M ago17:55

17:55

Unnecessary broad-spectrum antibiotics can drive antimicrobial resistance and cause adverse events, whereas inadequate antibiotic coverage is linked to increased mortality and length of stay for patients with bloodstream infections (BSIs). Listen now to learn from Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP), how to use rapid genotypic and p…

1
The Role of Antimicrobial Stewardship Programs in Implementing Rapid Phenotypic AST 27:38

2M ago27:38

27:38

Rapid phenotypic antimicrobial susceptibility testing (AST) significantly reduces time to actionable results and can improve antibiotic decision-making for patients with bloodstream infections. Listen in to learn from Michael P. Veve, PharmD, MPH, how to optimally integrate rapid phenotypic AST into clinical practice, including incorporation into y…

1
The Ongoing Challenge of Antimicrobial Selection for Bloodstream Infections 18:55

2M ago18:55

18:55

Sepsis and bloodstream infections (BSIs) are common and cause millions of deaths each year, with a disproportionate burden in low-income and middle-income countries. Tune in to learn from Jasmine R. Marcelin, MD, FACP, FIDSA, how inadequate antibiotic coverage can be linked to increased mortality and length of stay and how unnecessary broad-spectru…

1
Shopping insurances to keep rents down 8:06

1M ago8:06

8:06

What can be done to tenants ?

1
Role of Pharmacists in PrEP Delivery 45:22

2M ago45:22

45:22

Stream this podcast to learn from experts Tessa Rife-Pennington, PharmD, BCGP, and Frank North, PharmD, MPA, DPLA, DASPL, how specialty pharmacists can apply practical strategies within different pharmacy settings to overcome barriers to PrEP use, especially among underserved patient subpopulations. Topics covered include: PrEP candidacy Selection …

1
Episode 18: Understanding B cell responses to natural infection to design better vaccines 15:46

2M ago15:46

15:46

We talk with Dr. Florian Krammer, the endowed Mount Sinai Professor of Vaccinology at the Icahn School of Medicine, New York, NY and Director of the Ludwig Boltzmann Institute for Science Communication and Pandemic Preparedness at the Medical University of Vienna, Austria, who studies the B cell response in the context of natural infection to bette…

1
Episode 17: Using a rodent hepacivirus to uncover a role for iHALT during HCV infection 19:18

2M ago19:18

19:18

We talk with Dr. John Gridley, a postdoctoral fellow in the Vaccinology Training Program at Emory University, GA, who uses a hepatitis C virus-related rodent hepacivirus model to identify correlates of protective immunity for HCV and the role of inducible Hepatic-Associated Lymphoid Tissue (iHALT) in the induction of this immune response.…

1
Forging a Path Back to HIV Care 23:48

3M ago23:48

23:48

In this episode, expert patient navigators Shellye Jones and Lauren Jackson discuss the key take-home points of our online educational program on facilitating engagement in HIV care and propose a framework for effectively retaining people in care. Topics covered include: How to approach a patient with complex barriers to engagement in healthcare Re…

1
What it takes 17:06

2M ago17:06

17:06

This podcast gives a description of what it may take financially to produce or affordable housing in your area, but more specifically in the southeastern region of North Carolina

1
Overcoming Reluctance to Change as a Barrier to Optimizing ART for People Living With HIV and Viral Suppression 23:43

3M ago23:43

23:43

Don’t settle! Listen in to learn how a proactive approach to ART switch can improve treatment satisfaction and quality of life for people living with virologically suppressed HIV. Topics covered include: International AIDS Society (IAS) USA and European AIDS Clinical Society (EACS) Guidance on Switching ART With Viral Suppression Considerations for…

1
Episode 16: Creating healthy local communities to foster local to global impact 15:59

3M ago15:59

15:59

We talk with Dr. Sandro Galea, Dean and Professor of the School of Public Health at Washington University in St. Louis, who uses population based sciences to promote health locally and globally.By CVIMP

1
HIV “Blips”: What They Are (and Aren’t) 25:36

3M ago25:36

25:36

Detectable HIV-1 RNA (viral load) can seem very worrisome for people living with HIV who are receiving antiretroviral therapy (ART) and for their healthcare professionals. Tune in to learn how Brian R. Wood, MD, differentiates HIV-1 RNA “blips” from persistent low-level viremia and from virologic failure, and how he handles each scenario. Presenter…

1
Episode 15: Understanding B cell immune responses and memory to guide vaccine design 21:51

3M ago21:51

21:51

By CVIMP

1
Episode 14: Using Reverse Vaccinology 3.0 for Pandemic Preparedness 15:48

3M ago15:48

15:48

We talk with Dr. Emanuele Andreano, Head of Serology and Immunology at Fondazione Biotecnopolo di Siena, Italy, who combines immunology, structural biology and artificial intelligence to rapidly develop novel monoclonal antibodies therapies and antiviral vaccine targets.By CVIMP

1
Not a Statistic with Margaret Bordeaux 55:28

3M ago55:28

55:28

The Needle and the Narrative; Episode 2 – “Not a Statistic: BIPOC Health & Harm Reduction” We examine how systemic racism and health disparities heighten HIV risk for BIPOC communities, and uplift culturally responsive approaches and grassroots health interventions. Thank you to the Counter Narrative Project for making this series possible. Margare…

1
Individualizing Care for Treatment-Experienced People With HIV 15:45

3M ago15:45

15:45

Tune into this podcast from Dr Clíona Ní Cheallaigh to learn how to provide person-centered care for treatment-experienced people with HIV. Gain strategies to address each individual’s specific history and needs while considering the potential impact of comorbidities and other health challenges. Topics covered include: Individualizing Antiretrovira…

1
Clinical Scenarios Podcast: A Deep Dive Into Refractory CMV Infections 17:04

4M ago17:04

17:04

In this podcast, expert faculty Atul Humar, MD, FRCP (C), and Camille Kotton, MD, FIDSA, FAST, take a deep dive into complex clinical scenarios and explore designing antiviral regimens for refractory CMV infections to minimize antiviral toxicities and maximize efficacy. Topics covered include: Management for suspected drug-resistant CMV infection I…

1
Episode 13: Using structure-based design to develop novel antiviral therapeutics 25:22

4M ago25:22

25:22

We talk with Dr. Daniel Wrapp, Assistant Professor Assistant Professor at the Duke Human Vaccine Institute at Duke University School of Medicine, NC, who uses structure-based design to develop novel therapeutic interventions against viruses.By CVIMP

1
Soundings Podcast: Identifying Refractory CMV Infections in Transplant Settings 11:53

4M ago11:53

11:53

Tune in to learn the fundamentals for timely identification of refractory cytomegalovirus (CMV) infections following solid organ transplantation from expert faculty, Camille Kotton, MD, FIDSA, FAST. Topics covered include: Direct and indirect effects of CMV infection Risk factors for resistant/refractory CMV Defining resistant/refractory CMV Presen…

1
Charting the Course Podcast: Antivirals for Refractory CMV Infections 18:40

4M ago18:40

18:40

Learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections with expert faculty, Atul Humar, MD, FRCP (C). Topics covered include: Comparisons of available CMV antiviral therapies: Ganciclovir, valganciclovir, foscarnet, cidofovir, maribavir Considerations for renal…

1
The Patient Angle: Individualized Approaches for Managing CMV 25:22

4M ago25:22

25:22

Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable explore strategies for individualization of CMV management in high-risk kidney transplant recipients. Topics include: Risk factors and prevention of late-onset CMV disease Early detection of late CMV infection CMV cell-mediated immunity monitoring Primary and secondary prophylaxis Presenter…

1
The Viral Angle: CMV in Kidney Transplantation 13:26

4M ago13:26

13:26

Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable discuss the fundamentals of cytomegalovirus (CMV) in kidney transplant recipients. Topics include: CMV pathogenesis Direct and indirect effects of CMV infection Overview of patient risk factors CMV risk based on serologic status Presenters: Marcus Pereira, MD, MPH, FAST Associate Professor …

1
Syndromic Testing Podcast: Gastrointestinal and Joint Infections 20:30

4M ago20:30

20:30

Listen in as Dr Trevor Van Schooneveld explores rapid syndromic testing for gastrointestinal and joint infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing. Topics covered include: Who should be tested for infectious diarrhea Types of gastrointestinal syndromic panels Types of syndro…

1
The Antiviral Angle: Leveraging the Full CMV Armamentarium 10:42

4M ago10:42

10:42

Listen in as Dr Marcus Pereira discusses how to design cytomegalovirus (CMV) antiviral regimens for high-risk kidney transplant recipients to mitigate the impact of infection while minimizing drug toxicities. Topics include: Strategies for CMV prevention: prophylaxis, preemptive therapy, and hybrid methods Characteristics of available antiviral dru…

1
Heartbreak to Hope: My Journey With Meningitis Vaccine Advocacy 7:23

4M ago7:23

7:23

Join Alicia Stillman of the American Society for Meningitis Prevention, as she shares a very personal story of loss that might change how you view meningitis vaccination. Presenter: Alicia Stillman, MBA, MPH Patient Advocate Co-Executive Director, American Society for Meningitis Prevention Executive Director, Emily Stillman Foundation Detroit, Mich…

1
Syndromic Testing Podcast: Respiratory Infections 24:45

5M ago24:45

24:45

Listen in as Michael Satlin, MD, MS, FIDSA,explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing. Topics covered include: Types of upper and lower respiratory infection panels Considerations for when to use respiratory syndromic testing…

1
Advancing HIV Treatment: Leveraging Pharmacists’ Expertise 43:56

5M ago43:56

43:56

Stream this podcast to learn from experts Alexis E. Horace, PharmD, BCACP,andNimish Patel, PharmD, PhD, AAHIVP, how specialist pharmacists can overcome key barriers to care and apply best practices for optimization of antiretroviral therapy for HIV. Topics covered include: Leveraging pharmacists’ expertise to advance HIV treatment Pharmacist roles …

1
Lenacapavir Approval: What to Know When Selecting a PrEP Regimen 33:15

5M ago33:15

33:15

Tune in to learn how the recent FDA approval of lenacapavir (LEN) for PreP integrates into the current field of HIV prevention. Listen on the go or follow along with our expert-curated slides. Topics covered include: The current landscape of PrEP FDA approval of lenacapavir Phase III efficacy and safety data for lenacapavir Recommendations and pers…

1
Elderly losing their homes 14:49

5M ago14:49

14:49

How are the local municipalities/cities taking elderly homes?

1
Key HIV Studies Influencing My Practice Following IAS 2025—Dr Beatriz Grinsztejn and Rosie Mngqibisa 43:36

5M ago43:36

43:36

Hear from experts in HIV care Beatriz Grinsztejn, MD, PhD, and Rosie Mnggibisa, MBChB, MPH, as they discuss their insights on some of the most clinically relevant new data presented at IAS 2025, including studies on: Gaps in care for adolescents and young adults living with HIV Global impact of funding cuts Antiretroviral therapy for treating HIV P…

1
Syndromic Testing Podcast: Bloodstream Infections 19:09

5M ago19:09

19:09

Listen in as Dr Emily Heil explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing. Topics covered include: The importance of good blood culture practices and finding the balance between overuse and underuse Blood culture improvement prog…

1
Rural Harm Reduction with Michael Harney 58:10

5M ago58:10

58:10

Michael Harney from Western North Carolina AIDS Project (WNCAP). Intersecting Stories: HIV, Drug User Health, and Vulnerable Communities.This four-part series aims to amplify the voices of communities impacted by HIV, while exploring the role of harm reduction in addressing health disparities. Each episode focuses on a different vulnerable populati…

1
Fundamentals on Integrating Specialized Agents for Treatment-Experienced People With HIV 23:09

5M ago23:09

23:09

Tune in as Dr George Behrenspresents the fundamentals on specialized agents for treatment-experienced people living with HIV. Topics covered include: Key targets and mechanisms of action for specialized HIV drugs Clinical trial data supporting safety and efficacy of these agents Considerations for potential drug–drug interactions Strategies for lev…